- ►bmj.com SM Whitcup, LB Cantor, AM VanDenburgh, K … - British Medical Journal, 2003 - bjo.bmj.com Results: Bimatoprost once daily provided significantly lower mean IOP than
timolol twice daily at all times and follow up visits (p<0.001). At month 3,
mean IOP reductions from baseline at 10 am (peak timolol effect) were ... Cited by 23 - Related articles - BL Direct - All 8 versions
RJ Noecker, ML Earl, T Mundorf, J Peace, RD … - Advances in therapy, 2003 - Springer This randomized, investigator-masked, multicenter, parallel-design trial
compared the IOP-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in
African Americans with glaucoma or ocular hypertension. After a washout of ... Cited by 23 - Related articles - BL Direct - All 3 versions
[CITATION] Bimatoprost Study Groups 1 and 2. One-year, randomized study comparing bimatoprost and …
LB Cantor - Expert Opin. Drug Metab. Toxicol., 2005 - Informa Pharma Science Bimatoprost (Lumigan ® , Allergan) is a highly efficacious ocular hypotensive
agent that provides good diurnal control of intraocular pressure in glaucoma and
ocular hypertensive patients. Bimatoprost is a synthetic molecule that is ... Cited by 3 - Related articles - BL Direct - All 5 versions
LB Cantor, D WuDunn, A Cortes, J Hoop, S … - Survey of ophthalmology, 2004 - Elsevier At the baseline visit, there were no significant between-group differences in
IOP at 9 , 1 , or 4 (P≥.776). After 6 months of therapy, both medications
provided significant mean reductions from baseline IOP at every time point ... Cited by 25 - Related articles - All 5 versions
[CITATION] Comparison of once-or twice-daily bimatoprost with twice-daily timolol in patients with …
AHP Krauss, DF Woodward - Survey of ophthalmology, 2004 - Elsevier Bimatoprost is a novel and highly efficacious ocular hypotensive agent indicated
for the treatment of primary open-angle glaucoma and ocular hypertension.[5. and
30.] Bimatoprost is a synthetic molecule structurally and pharmacologically ... Cited by 19 - Related articles - All 4 versions
AL Coleman, F Lerner, P Bernstein, SM … - Ophthalmology, 2003 - Elsevier Presented in part at the annual meeting of the American Academy of
Ophthalmology, New Orleans, Louisiana, November 2001; and at the International
Congress of Ophthalmology, Sydney, Australia, April 2002. Cited by 32 - Related articles - All 4 versions
S Gandolfi, ST Simmons, R Sturm, K Chen, … - Advances in therapy, 2001 - Springer A multicenter, randomized, investigator-masked, parallel-group trial compared
bimatoprost and latanoprost for efficacy and safety in patients with glaucoma or
ocular hypertension. Patients received bimatoprost 0.03% (n = 119) or ... Cited by 111 - Related articles - BL Direct - All 4 versions
[CITATION] Bimatoprost/Latanoprost Study Group. A six-month randomized clinical trial comparing the …
